The Antidote Inside the World of New Pharma
Afbeeldingen
Artikel vergelijken
Uitgever: Simon & Schuster
Auteur:
Barry Werth
- Engels
- Paperback
- 9781451655674
- 23 december 2014
- 435 pagina's
Samenvatting
In this timely and much praised book, Barry Werth draws upon inside reporting that spans more than two decades. He provides a groundbreaking close-up of the upstart pharmaceutical company Vertex and the ferocious but indispensable world of Big Pharma that it inhabits.
In 1989, the charismatic Joshua Boger left Merck, then America&;s most admired business, to found a drug company that would challenge industry giants and transform health care. Werth described the company&;s tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex&;s bold endurance and eventual success.
The $325 billion-a-year pharmaceutical business is America&;s toughest and one of its most profitable. It&;s riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world&;s most regulated industry, matched only by nuclear power.
Werth captures the full scope of Vertex&;s twenty-five-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
In 1989, the charismatic Joshua Boger left Merck, then America&;s most admired business, to found a drug company that would challenge industry giants and transform health care. Werth described the company&;s tumultuous early days during the AIDS crisis in The Billion-Dollar Molecule, a celebrated classic of science and business journalism. Now he returns to tell a riveting story of Vertex&;s bold endurance and eventual success.
The $325 billion-a-year pharmaceutical business is America&;s toughest and one of its most profitable. It&;s riskier and more rigorous at just about every stage than any other business, from the towering biological uncertainties inherent in its mission to treat disease; to the 30-to-1 failure rate in bringing out a successful medicine even after a molecule clears all the hurdles to get to human testing; to the multibillion-dollar cost of ramping up a successful product; to operating in the world&;s most regulated industry, matched only by nuclear power.
Werth captures the full scope of Vertex&;s twenty-five-year drive to deliver breakthrough medicines. At a time when America struggles to maintain its innovative edge, The Antidote is a powerful inside look at one of the most intriguing and important business stories of recent decades.
Productspecificaties
Wij vonden geen specificaties voor jouw zoekopdracht '{SEARCH}'.
Inhoud
- Taal
- en
- Bindwijze
- Paperback
- Oorspronkelijke releasedatum
- 23 december 2014
- Aantal pagina's
- 435
- Illustraties
- Nee
Betrokkenen
- Hoofdauteur
- Barry Werth
- Hoofduitgeverij
- Simon & Schuster
Overige kenmerken
- Extra groot lettertype
- Nee
- Product breedte
- 150 mm
- Product hoogte
- 30 mm
- Product lengte
- 226 mm
- Studieboek
- Ja
- Verpakking breedte
- 226 mm
- Verpakking hoogte
- 29 mm
- Verpakking lengte
- 226 mm
- Verpakkingsgewicht
- 476 g
EAN
- EAN
- 9781451655674
Kies gewenste uitvoering
Kies je bindwijze
(2)
Prijsinformatie en bestellen
De prijs van dit product is 18 euro en 99 cent.
3 - 4 weken
Verkoop door bol
- Gratis verzending door bol vanaf 20 euro
- Ophalen bij een bol afhaalpunt mogelijk
- 30 dagen bedenktijd en gratis retourneren
- Dag en nacht klantenservice
Anderen bekeken ook
Vaak samen gekocht
Rapporteer dit artikel
Je wilt melding doen van illegale inhoud over dit artikel:
- Ik wil melding doen als klant
- Ik wil melding doen als autoriteit of trusted flagger
- Ik wil melding doen als partner
- Ik wil melding doen als merkhouder
Geen klant, autoriteit, trusted flagger, merkhouder of partner? Gebruik dan onderstaande link om melding te doen.